A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.	HER2-expressing Advanced Solid Tumors	Recruiting	Phase 1 / Phase 2	2024-08-05		NCT06015048

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jiangsu HengRui Medicine Co., Ltd.	132

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Provincial Hospital	Hefei	China	32
Guangxi Medical University Affiliated Tumor Hospital	Nanning	China	13
Harbin Medical University Cancer Hospital-The Eighth Department of Internal Medicine	Harbin	China	1
Henan Cancer Hospital	Zhengzhou	China	57
Hubei Cancer Hospital-Department of Abdominal Oncology	Wuhan	China	1
Hunan Cancer Hospital	Changsha	China	27
Peking University Cancer Hospital & Institute-Department of Gastrointestinal Oncology	Beijing	China	1
Shanxi Provincial Cancer Hospital-Gastroenterology Department	Taiyuan	China	1
The First Affiliated Hospital of Chongqing Medical University	Chongqing	China	70
The First Affiliated Hospital of Nanchang University	Nanchang	China	109
The First Affiliated Hospital of Xi'an Jiaotong University	Xi’an	China	29
The First Affiliated Hospital of Zhengzhou University-Department of Medical Oncology	Zhengzhou	China	1
the Fourth Hospital of Hebei Medical University	Shijiazhuang	China	19
The Second Affiliated Hospital of Nanchang University	Nanchang	China	3
Tianjin Medical University Cancer Institute and Hospital-Department of digestive oncology	Tianjin	China	1